Opas Traitanon

453 total citations
21 papers, 343 citations indexed

About

Opas Traitanon is a scholar working on Transplantation, Epidemiology and Nephrology. According to data from OpenAlex, Opas Traitanon has authored 21 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Transplantation, 7 papers in Epidemiology and 6 papers in Nephrology. Recurrent topics in Opas Traitanon's work include Renal Transplantation Outcomes and Treatments (11 papers), Cytomegalovirus and herpesvirus research (5 papers) and Dialysis and Renal Disease Management (4 papers). Opas Traitanon is often cited by papers focused on Renal Transplantation Outcomes and Treatments (11 papers), Cytomegalovirus and herpesvirus research (5 papers) and Dialysis and Renal Disease Management (4 papers). Opas Traitanon collaborates with scholars based in Thailand, United States and Italy. Opas Traitanon's co-authors include Yingyos Avihingsanon, Lorenzo Gallon, James M. Mathew, Valeria R. Mas, Paungpaga Lertdumrongluk, Somratai Vadcharavivad, Poorichaya Somparn, Wonngarm Kittanamongkolchai, Emilio D. Poggio and Robert L. Fairchild and has published in prestigious journals such as PLoS ONE, Kidney International and Frontiers in Immunology.

In The Last Decade

Opas Traitanon

18 papers receiving 338 citations

Peers

Opas Traitanon
A. McLean United Kingdom
R. Bardi Tunisia
Isabel Roberti United States
Peter Dupont United Kingdom
Sevgi Gurkan United States
Opas Traitanon
Citations per year, relative to Opas Traitanon Opas Traitanon (= 1×) peers Janka Slatinská

Countries citing papers authored by Opas Traitanon

Since Specialization
Citations

This map shows the geographic impact of Opas Traitanon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Opas Traitanon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Opas Traitanon more than expected).

Fields of papers citing papers by Opas Traitanon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Opas Traitanon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Opas Traitanon. The network helps show where Opas Traitanon may publish in the future.

Co-authorship network of co-authors of Opas Traitanon

This figure shows the co-authorship network connecting the top 25 collaborators of Opas Traitanon. A scholar is included among the top collaborators of Opas Traitanon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Opas Traitanon. Opas Traitanon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chancharoenthana, Wiwat, Opas Traitanon, Asada Leelahavanichkul, & Claudio Ronco. (2025). Optimizing hepatitis B vaccination in chronic kidney disease: a comprehensive scoping review of strategies across CKD stages, dialysis, and transplant populations. Renal Failure. 47(1). 2541873–2541873.
2.
Chancharoenthana, Wiwat, Wassawon Ariyanon, Hailong Hu, et al.. (2025). Significance of neutrophil extracellular traps and low-density granulocytes in advanced chronic kidney disease (stage 5D) cases with COVID-19. Renal Failure. 47(1). 2559093–2559093.
3.
Chancharoenthana, Wiwat, Opas Traitanon, Asada Leelahavanichkul, & Adis Tasanarong. (2023). Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review. Frontiers in Immunology. 14. 1206929–1206929. 8 indexed citations
4.
Yuenyongchaiwat, Kornanong, et al.. (2021). Efficiency of the Respiratory Training Prototype for Application in Hemodialysis Patients: a Preliminary Study. The Philippine journal of science. 150(5).
5.
Yuenyongchaiwat, Kornanong, et al.. (2021). Depression and low physical activity are related to sarcopenia in hemodialysis: a single-center study. PeerJ. 9. e11695–e11695. 18 indexed citations
6.
Yuenyongchaiwat, Kornanong, et al.. (2020). Effectiveness of inspiratory muscle training on respiratory fitness and breathlessness in chronic renal failure: A randomized control trial. Physiotherapy Research International. 26(1). e1879–e1879. 12 indexed citations
8.
Anutrakulchai, Sirirat, et al.. (2017). 320 Urine tweak protein is a novel biomarker for resistant-to-treat lupus nephritis. A143.3–A144. 2 indexed citations
9.
Traitanon, Opas, et al.. (2016). Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis. International Journal of Nephrology. 2016. 1–8. 10 indexed citations
10.
Traitanon, Opas, et al.. (2015). Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. PLoS ONE. 10(6). e0129658–e0129658. 39 indexed citations
11.
Gallon, Lorenzo, Opas Traitanon, Yuming Yu, et al.. (2015). Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. Transplantation. 99(9). 1774–1784. 49 indexed citations
12.
Traitanon, Opas, Emilio D. Poggio, & Robert L. Fairchild. (2014). Molecular monitoring of alloimmune-mediated injury in kidney transplant patients. Current Opinion in Nephrology & Hypertension. 23(6). 625–630. 15 indexed citations
13.
Gallon, Lorenzo, Opas Traitanon, Nedjema Sustento‐Reodica, et al.. (2014). Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. Kidney International. 87(4). 828–838. 29 indexed citations
14.
Traitanon, Opas & Lorenzo Gallon. (2014). Chimerism and Tolerance Induction in Kidney Transplantation. ˜The œNephron journals/Nephron journals. 129(1). 34–38. 4 indexed citations
15.
Traitanon, Opas, Anton V. Gorbachev, Karen S. Keslar, et al.. (2014). IL-15 Induces Alloreactive CD28− Memory CD8 T Cell Proliferation and CTLA4-Ig Resistant Memory CD8 T Cell Activation. American Journal of Transplantation. 14(6). 1277–1289. 35 indexed citations
16.
Traitanon, Opas, et al.. (2014). Conversion From Tacrolimus to Sirolimus Results in Expansion of CD4+25hiFoxp3+ T Cells.. Transplantation. 98. 113–114. 1 indexed citations
17.
Gallon, Lorenzo, Ricardo C. Gehrau, Joseph R. Leventhal, et al.. (2014). Chronic Immune Activation After Sirolimus Conversion in Kidney Transplant Recipients.. Transplantation. 98. 112–113. 2 indexed citations
18.
Punyawudho, Baralee, Paungpaga Lertdumrongluk, Poorichaya Somparn, et al.. (2012). Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients. International Journal of Clinical Pharmacology and Therapeutics. 50(4). 272–280. 15 indexed citations
19.
Lertdumrongluk, Paungpaga, Poorichaya Somparn, Wonngarm Kittanamongkolchai, et al.. (2010). Pharmacokinetics of mycophenolic acid in severe lupus nephritis. Kidney International. 78(4). 389–395. 64 indexed citations
20.
Traitanon, Opas, Yingyos Avihingsanon, Natavudh Townamchai, et al.. (2008). Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study. Lupus. 17(8). 744–751. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026